Have a personal or library account? Click to login
The evaluation of the efficiency and safety of hyperbaric oxygen therapy for COVID-19 in a female patient with a congenital heart disease – case study Cover

The evaluation of the efficiency and safety of hyperbaric oxygen therapy for COVID-19 in a female patient with a congenital heart disease – case study

Pomeranian Journal of Life Sciences
Volume 70 (2024): Issue 4 (December 2024)
By: Ada Lisowska,  Katarzyna Szwamel and  Tomasz Sochacki  
Open Access
|Feb 2025

References

  1. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus – infected pneumonia in Wuhan, China. JAMA 2020;323(11):1061-9. doi: 10.1001/ jama.2020.1585.
    Search in Google ScholarBack to article
  2. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;382(18):1708-20. doi: 10.1056/NEJMoa2002032.
    Search in Google ScholarBack to article
  3. WHO COVID 19 dashboard. World Health Organization. https://covid19.who.int/ (10.01.2024)
    Search in Google ScholarBack to article
  4. Koronawirus: informacje i zalecenia. Raport zakażeń koronawirusem (SARS-CoV-2). Serwis Rzeczypospolitej Polskiej. https://www.gov.pl/web/koronawirus/wykaz-zarazen-koronawirusem-sars-cov-2 (10.01.2022).
    Search in Google ScholarBack to article
  5. Coronavirus disease (COVID-19). World Health Organization. https://www.who.int/health-topics/coronavirus#tab=tab_1 (8.06.2022).
    Search in Google ScholarBack to article
  6. Geier MR, Geier DA. Respiratory conditions in coronavirus disease 2019 (COVID-19): Important considerations regarding novel treatment strategies to reduce mortality. Med Hypotheses 2020;140:109760. doi: 10.1016/j. mehy.2020.109760.
    Search in Google ScholarBack to article
  7. Senniappan K, Jeyabalan S, Rangappa P, Kanchi M. Hyperbaric oxygen therapy: can it be a novel supportive therapy in COVID19? Indian J Anaesth 2020;64(10):835-41. doi: 10.4103/ija.IJA_613_20.
    Search in Google ScholarBack to article
  8. Ghosh G. COVID-19 and HBOT: a conceptual standpoint. J Mar Med Soc 2020;22:S133-4. doi: 10.4103/jmms.jmms_112_20.
    Search in Google ScholarBack to article
  9. Petrikov SS, Evseev AK, Levina OA, Shabanov AK, Kulabukhov VV, Kutrovskaya NY, et al. Hyperbaric oxygen therapy in patients with COVID-19. General Reanimatol 2020;16(6):4-18. doi: 10.15360/1813-9779-2020-6-4-18.
    Search in Google ScholarBack to article
  10. Halbach JL, Prieto JM, Wang AW, Hawisher D, Cauvi DM, Reyes T, et al. Early hyperbaric oxygen therapy improves survival in a model of severe sepsis. Am J Physiol Regul Integr Comp Physiol 2019;317(1):R160-8. doi: 10.1152/ajpregu.00083.2019.
    Search in Google ScholarBack to article
  11. Gottfried I, Schottlender N, Ashery U. Hyperbaric oxygen treatment – from mechanisms to cognitive improvement. Biomolecules 2021;11(10):1520. doi: 10.3390/biom11101520.
    Search in Google ScholarBack to article
  12. Narożny W, Siebert J. Możliwości i ograniczenia stosowania tlenu hiperbarycznego w medycynie. Forum Med Rodz 2007;1(4):368-75.
    Search in Google ScholarBack to article
  13. Boerema I, Meyne NG, Brummelkamp WK, Bouma S, Mensch MH, Kamermans F, et al. Life without blood: a study of the influence of high atmospheric pressure and hypothermia on dilution of the blood. J Cardiovasc Surg 1959;13:133-46.
    Search in Google ScholarBack to article
  14. Łatka U, Kuliński W, Knefel G, Sieroń A. Aktualny stan medycyny hiperbarycznej w Polsce. Baln Pol 2009;1:7-17.
    Search in Google ScholarBack to article
  15. Longobardi P, Hoxha K, Perreca F. Is hyperbaric oxygen effective treatment for the prevention of complications in Sars-CoV-2 asymptomatic patients? Infect Microbes Dis 2021;3(2):109-11. doi: 10.1097/ IM9.0000000000000064.
    Search in Google ScholarBack to article
  16. Harch PG. Hyperbaric oxygen treatment of novel coronavirus (COVID-19) respiratory failure. Med Gas Res 2020;10(2):61-2. doi: 10.4103/2045-9912.282177.
    Search in Google ScholarBack to article
  17. Fracica PJ, Knapp MJ, Piantadosi CA, Takeda K, Fulkerson WJ, Coleman RE, et al. Responses of baboons to prolonged hyperoxia: physiology and qualitative pathology. J Appl Physiol (1985) 1991;71(6):2352-62. doi: 10.1152/ jappl.1991.71.6.2352.
    Search in Google ScholarBack to article
  18. Yanagawa Y. Current status of hyperbaric oxygen therapy for COVID-19. Acute Med Surg 2021;8(1):e678. doi: 10.1002/ams2.678.
    Search in Google ScholarBack to article
  19. EUBS & ECHM position statement on the use of Hyperbaric Oxygen Therapy (HBOT) for treatment of COVID-19 patients. European Committee for Hyper-baric Medicine. http://www.echm.org/documents/English-ECHM-EUBS-position-on-the-use-of-HBOT-for-COVID-19-1st-May-2020.pdf (8.06.2022).
    Search in Google ScholarBack to article
  20. Kjellberg A, De Maio A, Lindholm P. Can hyperbaric oxygen safety serve as an anti-inflammatory treatment for COVID-19? Med Hypotheses 2020;144:110224. doi: 10.1016/j.mehy.2020.110224.
    Search in Google ScholarBack to article
  21. De Maio A, Hightower LE. COVID-19, acute respiratory distress syndrome (ARDS), and hyperbaric oxygen therapy (HBOT): what is the link? Cell Stress Chaperones 2020;25(5):717-20. doi: 10.1007/s12192-020-01121-0.
    Search in Google ScholarBack to article
  22. Paganini M, Bosco G, Perozzo FAG, Kohlscheen E, Sonda R, Bassetto F, et al. The role of hyperbaric oxygen treatment for COVID-19: a review. Adv Exp Med Biol 2021;1289:27-35. doi: 10.1007/5584_2020_568.
    Search in Google ScholarBack to article
  23. Bosco G, Vezzani G, Mrakic Sposta S, Rizzato A, Enten G, Abou-Samra A, et al. Hyperbaric oxygen therapy ameliorates osteonecrosis in patients by modulating inflammation and oxidative stress. J Enzyme Inhib Med Chem 2018;33(1):1501-5. doi: 10.1080/14756366.2018.1485149.
    Search in Google ScholarBack to article
  24. Dulai PS, Buckey JC Jr, Raffals LE, Swoger JM, Claus PL, O‘Toole K, et al. Hyperbaric oxygen therapy is well tolerated and effective for ulcerative colitis patients hospitalized for moderate-severe flares: a phase 2A pilot multi-center, randomized, double-blind, sham-controlled trial. Am J Gastroenterol 2018;113(10):1516-23. doi: 10.1038/s41395-018-0005-z.
    Search in Google ScholarBack to article
  25. Wardhani S, Suryokusumo MG, Putri NRA. Hyperbaric oxygen therapy for ‘happy’ hypoxia in COVID-19 patients, why is it better? Adv Health Sci Res 2020;30:110-24. doi: 10.2991/ahsr.k.201125.020.
    Search in Google ScholarBack to article
  26. El Hawa AAA, Charipova K, Bekeny JC, Johnson-Arbor KK. The evolving use of hyperbaric oxygen therapy during the COVID-19 pandemic. J Wound Care 2021;30(Sup2):S8-11. doi: 10.12968/jowc.2021.30.Sup2.S8.
    Search in Google ScholarBack to article
  27. Kim HS, Choi MH, Baek JH, Park SJ, Lee JC, Jeong UH, et al. Effects of 92% oxygen administration on cognitive performance and physiological changes of intellectually and developmentally disabled people. J Physiol Anthropol 2015;34(1):3. doi: 10.1186/s40101-015-0043-9.
    Search in Google ScholarBack to article
  28. Atisook R, Euasobhon P, Saengsanon A, Jensen MP. Validity and utility of four pain intensity measures for use in international research. J Pain Res 2021;14:1129-39. doi: 10.2147/JPR.S303305.
    Search in Google ScholarBack to article
  29. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999;54(7):581-6. doi: 10.1136/thx.54.7.581.
    Search in Google ScholarBack to article
  30. Zhong X, Tao X, Tang Y, Chen R. The outcomes of hyperbaric oxygen therapy to retrieve hypoxemia of severe novel coronavirus pneumonia: first case report. Zhonghua Hanghai Yixue yu Gaoqiya Yixue Zazhi 2020. doi: 10.3760/cma.j.issn.1009-6906.2020.0001.
    Search in Google ScholarBack to article
  31. Zhong XL, Niu XQ, Tao XL, Chen RY, Liang Y, Tang YC. The first case of HBOT in critically ill endotracheal intubation patient with COVID-19. Beijing: Novel Coronavirus Pneumonia Research Network Sharing Platform of China Association for Science and Technology; 2020.
    Search in Google ScholarBack to article
  32. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5.
    Search in Google ScholarBack to article
  33. Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020;8(5):475-81. doi: 10.1016/S2213-2600(20)30079-5.
    Search in Google ScholarBack to article
  34. Liang Y, Fan N, Zhong X, Fan W. A case report of a patient with severe type of coronavirus disease 2019 (COVID-19) treated by hyperbaric oxygen: CT dynamic changes. Iran J Radiol 2020;17(4):e104475. doi: 10.5812/ iranjradiol.104475.
    Search in Google ScholarBack to article
  35. Hadanny A, Shachar F, Merav C, Razia AH, Calanit K, Gabriella L, et al. Hyperbaric oxygen therapy for COVID-19 patients: a prospective, randomised controlled trial. Int J Phys Med Rehabil 2022;10(2):1000624.
    Search in Google ScholarBack to article
  36. Gorenstein SA, Castellano ML, Slone ES, Gillette B, Liu H, Alsamarriae C, et al. Hyperbaric oxygen therapy for COVID-19 patients with respiratory distress: treated cases versus propensity-matched controls. Undersea Hyperb Med 2020;47(3):405-13. doi: 10.22462/01.03.2020.1.
    Search in Google ScholarBack to article
  37. Guo D, Pan S, Wang M, Guo Y. Hyperbaric oxygen therapy may be affective to improve hypoxemia in patients with severe COVID-19 pneumonia: two case reports. Undersea Hyperb Med 2020;47(2):181-7. doi: 10.22462/04.06.2020.2.
    Search in Google ScholarBack to article
  38. Raskin A, Gershon S, Crook TH, Sathanathan G, Ferris S. The effects of hyperbaric and normobaric oxygen on cognitive impairment in the elderly. Arch Gen Psychiatry 1978;35(1):50-6. doi: 10.1001/ archpsyc.1978.01770250052005.
    Search in Google ScholarBack to article
  39. Kamat SM, Mendelsohn AR, Larrick JW. Rejuvenation through oxygen, more or less. Rejuvenation Res 2021;24(2):158-63. doi: 10.1089/rej.2021.0014.
    Search in Google ScholarBack to article
  40. Harlan NP, Ptak JA, Rees JR, Cowan DR, Fellows AM, Kertis JA, et al. Development of an international, multicentre, hyperbaric oxygen treatment registry and research consortium: protocol for outcome data collection and analysis. JMIR Res Protoc 2020;9(8):e18857. doi: 10.2196/18857.
    Search in Google ScholarBack to article
  41. Kjellberg A, Douglas J, Pawlik MT, Kraus M, Oscarsson N, Zheng X, et al. Randomised, controlled, open label, multicentre clinical trial to explore safety and efficacy of hyperbaric oxygen for preventing ICU admission, morbidity and mortality in adult patients with COVID-19. BMJ Open 2021;11(7):e046738. doi: 10.1136/bmjopen-2020-046738.
    Search in Google ScholarBack to article
DOI: https://doi.org/10.21164/pomjlifesci.1003 | Journal eISSN: 2719-6313 | Journal ISSN: 2450-4637
Journal RSS Feed
Language: English
Page range: 31 - 37
Published on: Feb 21, 2025
Published by: Pomeranian Medical University
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
hyperbaric oxygen,
therapy,
safety,
COVID-19 disease,
congenital heart defect,
patent foramen ovale
Related subjects:
Medicine,
Basic medical science,
Basic medical science, other,
Clinical medicine,
Surgery,
Surgery, other,
Public health

© 2025 Ada Lisowska, Katarzyna Szwamel, Tomasz Sochacki, published by Pomeranian Medical University
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 70 (2024): Issue 4 (December 2024)Next article